120 related articles for article (PubMed ID: 2566453)
1. Computer analysis of the effect of beta-endorphin and dynorphin and related compounds on opioid binding to mouse brain membrane.
Landahl HD; Garzon J; Lee NM
Comput Biol Med; 1989; 19(3):151-62. PubMed ID: 2566453
[TBL] [Abstract][Full Text] [Related]
2. Dynorphin(1-13), a long-lasting inhibitor of opiate receptor binding in vitro.
Garzón J; Jen MF; Sánchez-Blázquez P; Lee NM
Life Sci; 1982 Oct 18-25; 31(16-17):1789-92. PubMed ID: 6130441
[No Abstract] [Full Text] [Related]
3. Evidence for multiple "Kappa" binding sites by use of opioid peptides in the guinea-pig lumbo-sacral spinal cord.
Attali B; Gouardères C; Mazarguil H; Audigier Y; Cros J
Neuropeptides; 1982 Oct; 3(1):53-64. PubMed ID: 6296719
[TBL] [Abstract][Full Text] [Related]
4. Opiate receptor binding profile in the rabbit cerebellum and brain membranes.
Ho CL; Hammonds RG; Li CH
Biochem Pharmacol; 1985 Apr; 34(7):925-31. PubMed ID: 2985086
[TBL] [Abstract][Full Text] [Related]
5. The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.
Khawaja XZ; Green IC; Thorpe JR; Titheradge MA
Biochem J; 1990 Apr; 267(1):233-40. PubMed ID: 1970240
[TBL] [Abstract][Full Text] [Related]
6. The binding to rat brain homogenates of Mr2034, a universal opiate.
Johnson N; Pasternak GW
Life Sci; 1983 Sep; 33(10):985-91. PubMed ID: 6310291
[TBL] [Abstract][Full Text] [Related]
7. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
De Souza EB; Schmidt WK; Kuhar MJ
J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
[TBL] [Abstract][Full Text] [Related]
8. Detection and characterization of four binding sites for opioids in the mouse brain.
Neil A
Acta Pharmacol Toxicol (Copenh); 1985 Feb; 56(2):108-16. PubMed ID: 2986409
[TBL] [Abstract][Full Text] [Related]
9. Comparison of mu, delta, and kappa opiate binding sites in rat brain and spinal cord.
Mack KJ; Killian A; Weyhenmeyer JA
Life Sci; 1984 Jan; 34(3):281-5. PubMed ID: 6319937
[TBL] [Abstract][Full Text] [Related]
10. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
Su TP
J Pharmacol Exp Ther; 1985 Jan; 232(1):144-8. PubMed ID: 2856939
[TBL] [Abstract][Full Text] [Related]
11. Relation of diltiazem binding sites to opioid receptor subtypes in the guinea-pig brain.
Ishizuka Y; Oka T
Tokai J Exp Clin Med; 1987 Mar; 12(1):11-7. PubMed ID: 2835832
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of 3H-tifluadom binding in guinea-pig brain membranes.
Burkard WP; Müller PM; Flück N
J Recept Res; 1984; 4(1-6):165-73. PubMed ID: 6151988
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the kappa-subtype of the opiate receptor in the guinea-pig brain.
Kosterlitz HW; Paterson SJ; Robson LE
Br J Pharmacol; 1981 Aug; 73(4):939-49. PubMed ID: 6268235
[TBL] [Abstract][Full Text] [Related]
14. Regional interactions of opioid peptides at mu and delta sites in rat brain.
Hewlett WA; Barchas JD
Peptides; 1983; 4(6):853-8. PubMed ID: 6324140
[TBL] [Abstract][Full Text] [Related]
15. [3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type.
Garzón J; Sánchez-Blázquez P; Lee NM
J Pharmacol Exp Ther; 1984 Oct; 231(1):33-7. PubMed ID: 6092603
[TBL] [Abstract][Full Text] [Related]
16. Affinities of some common opioid analgesics towards four binding sites in mouse brain.
Neil A
Naunyn Schmiedebergs Arch Pharmacol; 1984 Nov; 328(1):24-9. PubMed ID: 6151117
[TBL] [Abstract][Full Text] [Related]
17. Differentiating aspects of opioid receptor binding by [3H](-) (1R,5R,9R,2''S)-5,9-dimethyl-2-tetrahydrofurfuryl-2'-hydroxy-6,7- benzomorphan hydrochloride ([3H]Mr 2034), a drug preferentially acting on kappa-receptors.
Ensinger HA
Arzneimittelforschung; 1985; 35(1A):447-51. PubMed ID: 2985096
[TBL] [Abstract][Full Text] [Related]
18. Interactions of codeine-7,8-oxide (codeine-epoxide), as a new metabolite of codeine, with multiple opiate receptors.
Konno F; Sato Y; Togashi K; Takayanagi I; Hirobe M
Gen Pharmacol; 1985; 16(4):379-81. PubMed ID: 2995195
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of stimulation strength in mouse vas deferens on inhibition of neuroeffector transmission by receptor type selective opioids.
Ramme D; Illes P
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan; 332(1):57-61. PubMed ID: 2869418
[TBL] [Abstract][Full Text] [Related]
20. Opiate and opioid peptide binding in rat goldfish: further evidence for opiate receptor heterogeneity.
Nishimura S; Pasternak GW
Brain Res; 1982 Sep; 248(1):192-5. PubMed ID: 6289993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
